BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Memento EPFL//
BEGIN:VEVENT
SUMMARY:Enabling Technologies for the Green Synthesis of Pharmaceutical Ag
 ents
DTSTART:20200609T161500
DTEND:20200609T173000
DTSTAMP:20260610T154921Z
UID:f6f458e1bb811275f3983a23bdf62de1f3ef5e5a1b63eff0e353e2ec
CATEGORIES:Conferences - Seminars
DESCRIPTION:Dr. Rebecca Ruck Dr. Rebecca T. Ruck joined Merck Research Lab
 oratories\, Process Research & Development in 2005 and is currently Execut
 ive Director of Enabling Technologies\, PR&D in Rahway\, NJ. Her team is t
 asked with leveraging its expertise in areas such as Catalysis\, Biotechno
 logy and Flow Chemistry to enable processes for APIs in the MSD pipeline a
 nd developing new capabilities that will allow us to continue to do so int
 o the future. Becky previously served as Director of three different teams
 : Process Chemistry\, Catalysis & Automation and Discovery Process Chemist
 ry. Over the course of her career\, Becky and her team have impacted proje
 cts across a range of therapeutic areas\, including beta-lactamase inhibit
 ors\, hepatitis C and diabetes.   Becky earned her A.B. summa cum laude f
 rom Princeton University in 1998. She received a Ph.D. from Harvard Univer
 sity in 2003\, where she was an NSF Fellow in the research group of Profes
 sor Eric Jacobsen. Following graduate studies\, Becky served as an NIH pos
 t-doctoral fellow in the lab of Professor Robert Bergman at the University
  of California\, Berkeley. She has a real passion for driving Women in Che
 mistry activities and was named the 2018 winner of the ACS Award for Encou
 raging Women into Careers in the Chemical Sciences.  \nInvestment in new 
 technologies enables the pharmaceutical industry to develop innovative and
  sustainable processes for the preparation of Active Pharmaceutical Ingred
 ients. This presentation will highlight several of the new capabilities in
  which MSD has invested and the corresponding synthetic benefits gained. U
 ltimately\, these innovative investments have enabled the development of c
 reative processes now being used to prepare marketed and late stage therap
 eutics in an environmentally benign fashion.
LOCATION:Zoom https://epfl.zoom.us/j/93987751724
STATUS:CONFIRMED
END:VEVENT
END:VCALENDAR